Malignant transformation occurs in cells that overexpress c-Myc or that ina
ppropriately activate E2F-1. Transformation occurs after the selection of c
ells that have acquired resistance to apoptosis that is triggered by these
oncogenes, and a key mediator of this cell death process is the p53 tumor s
uppressor. In IL-3-dependent immortal 32D.3 myeloid cells the ARF/p53 apopt
otic pathway is inactivated, as these cells fail to express ARF. Nonetheles
s, both c-Myc and E2F-1 overexpression accelerated apoptosis when these cel
ls were deprived of IL-3. Here we report that c-Myc or E2F-1 overexpression
suppresses Bcl-2 protein and RNA levels, and that restoration of Bcl-2 pro
tein effectively blocks the accelerated apoptosis that occurs when c-Myc- o
r E2F-1-overexpressing cells are deprived of IL-3. Blocking p53 activity wi
th mutant p53 did not abrogate E2F-1-induced suppression of Bcl-2. Analysis
of immortal myeloid cells engineered to overexpress c-Myc and E2F-1 DNA bi
nding mutants revealed that DNA binding activity of these oncoproteins is r
equired to suppress Bcl-2 expression. These results suggest that the target
ing of Bcl-2 family members is an important mechanism of oncogene-induced a
poptosis, and that this occurs independent of the ARF/p53 pathway.